EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care

Brett M Colbert, Molly Smeal, Zachary J Cromar, Potyra Rosa, Susan H Blanton, Byron L Lam, Xue Z Liu iD

The Laryngoscope · 2025

DOI: 10.1002/lary.31911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Brett M Colbert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, U.S.A. Hauptthemen laut MEDLINE: Usher Syndromes, Genetic Testing, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCD NIH HHS, Research to Prevent Blindness-Unrestricted Grant, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Usher syndrome (USH) is a rare, autosomal‐recessive genetic disorder and a leading cause of early onset deaf‐blindness. A clinical diagnosis is made by the presence of retinitis pigmentosa (RP) with sensorineural hearing loss (SNHL). Subtype (USH1, USH2, USH3) is determined by severity and age of onset. Molecular testing is able to further distinguish USH subtypes by causative gene. As gene therapy strategies continue to be explored for USH, it is important to know the underlying genetic cause and to coordinate care among an interdisciplinary team.

Methods

We reviewed charts of 198 individuals presenting to the RP clinic at Bascom Palmer Eye Institute (BPEI) for suspected USH. Demographic information, USH clinical diagnosis, molecular testing, molecular diagnosis, and audiological data were collected.

Results

Of the 198 patients reviewed, 190 (96%) met clinical criteria for USH and received a clinical diagnosis. There were 67 (35%) that had a genetic test with a pathogenic molecular diagnosis. The average ages at molecular diagnosis were USH1B, 20 years old; USH2A, 37 years old; USH2C, 50 years old. Of the 67 with a molecular diagnosis, 23 (34%) established ophthalmic care and 8 of these (11%) established audiological care. Discussion/Conclusion Molecular testing and diagnosis should be part of the routine care of USH individuals to facilitate earlier interventions and coordinated care between ophthalmology and audiology. Level of Evidence 4 Laryngoscope , 135:1777–1780, 2025

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Usher SyndromesGenetic TestingMolecular Diagnostic TechniquesHumansAdultMaleFemaleMiddle AgedPrevalenceChildYoung AdultAdolescentRetrospective StudiesChild, PreschoolAgedExtracellular Matrix Proteins

Stichwörter der Autor:innen

Coordinated careMolecular diagnosisRetinitis pigmentosaSensorineural hearing lossUsher syndrome

Substanzen

USH2A protein, humanExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.
  • Medical Scientist Training Program, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.
  • Dr. John T. Macdonald Foundation Department of Human Genetics, John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.
  • Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.
  • Department of Biochemistry, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.

ORCID-Profile: Xue Z Liu

Förderung

  • NIDCD NIH HHS
  • Research to Prevent Blindness-Unrestricted Grant
  • NEI NIH HHS
  • National Eye Institute
  • National Institute on Deafness and Other Communication Disorders

Zitieren

APA

Colbert, B. M., Smeal, M., Cromar, Z. J., Rosa, P., Blanton, S. H., Lam, B. L., & Liu, X. Z. (2025). Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care. The Laryngoscope. https://doi.org/10.1002/lary.31911

Vancouver

Colbert BM, Smeal M, Cromar ZJ, Rosa P, Blanton SH, Lam BL, et al. Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care. The Laryngoscope. 2025. doi:10.1002/lary.31911

BibTeX
@article{Colbert2025,
  author = {Colbert, Brett M and Smeal, Molly and Cromar, Zachary J and Rosa, Potyra and Blanton, Susan H and Lam, Byron L and Liu, Xue Z},
  title = {Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.31911}
}
Kostenlos starten →